EMAIL DETAILS
SUBJECT:
Fwd: Treatment
PRI: NORMAL
FROM:
H
halliebiden@gmail.com
DATE:
2014-12-18 20:29:28
MSG_ID:
<CAC0fNc_bewEmeyvrtwxjq_BardbZAF6Pne7dz-e5_5wzqQtR5g@mail.gmail.com>
RECIPIENTS:
TO:
2
jim smith
<261penn@gmail.com>
H
Hunter Biden
<hbiden@rosemontseneca.com>
T
Ashley Biden
<trailblazerbiden@gmail.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Spoke to Al- he was not concerned with the MRI. Said it was most likely just a different slice/angle of mri. Also spoke with Al about possibly easing up and not doing the next/final dose of CCNU. Seems to really take a toll on Beau. Maybe taking a few weeks break (or more or less) and then starting the immune therapy. The avastin would continue and complement the immune therapy. I just got this from Jon and keeping you in the loop. Xx ---------- Forwarded message ---------- From: Jon Glass <Jon.Glass@jefferson.edu> Date: Thu, Dec 18, 2014 at 3:15 PM Subject: Treatment To: Hallie <halliebiden@gmail.com>, "261penn@gmail.com" <261penn@gmail.com> Dr. Yung agrees that the Avastin should be continued. We will hold off on the CCNU for now and he had an idea for a new therapy (one of the immue therapies we discussed last night). I put in orders for labs for tomorrow if they have not already been done. What time is the infusion? Jon Glass, MD The information contained in this transmission contains privileged and confidential information. It is intended only for the use of the person named above. If you are not the intended recipient, you are hereby notified that any review, dissemination, distribution or duplication of this communication is strictly prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message. *CAUTION*: Intended recipients should NOT use email communication for emergent or urgent health care matters. -- Hallie Olivere Bide
METADATA:
THREAD:
INDEX:
AdhhnwFt6vD2gqOrR2uCJb1a/9tbJg==
REFERENCES:
REPLY_TO:
<1418933721184.37412@jefferson.edu>
REFS:
<1418933721184.37412@jefferson.edu>